BiotechTube
Newbury Pharmaceuticals

Newbury Pharmaceuticals

Stockholm, Sweden· Est.
newburypharma.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Newbury Pharmaceuticals, founded in 2021 and based in Stockholm, Sweden, is a regional commercial-stage pharma company with a hybrid business model. It leverages deep Nordic market expertise to in-license and exclusively distribute pharmaceutical products, positioning itself as a flexible alternative to large multinationals. The company is led by an experienced team with backgrounds at firms like AbbVie and Bluefish Pharmaceuticals and is focused on expanding its footprint in specialty and branded medicines. Its strategy centers on operational excellence in regulatory affairs, market access, and commercialization to create lasting impact in healthcare.

Drug DeliverySmall Molecules

Technology Platform

Integrated commercial and regulatory platform for the Nordic market, specializing in market access, supply chain, and commercialization as a Marketing Authorization Holder (MAH) and exclusive distributor.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The growing trend of large pharma outsourcing commercialization of niche or mature products in smaller, complex markets like the Nordics presents a significant opportunity.
Further expansion into high-value specialty medicines can drive margin growth and solidify its position as a key regional partner.

Risk Factors

Revenue is dependent on securing and maintaining successful licensing/distribution agreements, creating partner concentration and portfolio renewal risks.
The company also bears full regulatory and market access liability for products where it acts as Marketing Authorization Holder, exposing it to reimbursement challenges.

Competitive Landscape

Newbury competes with the local subsidiaries of large multinational pharmaceutical companies, other Nordic-focused hybrid/commercial pharma firms (e.g., similar to Bluefish Pharmaceuticals), and broad-line pharmaceutical distributors. Its differentiation lies in its focused regional expertise, flexible partnership model, and integrated MAH capabilities.

More companies in Sweden →